leukemia Archives - Page 2 of 5

01/05/2019

Results ‘encouraging’ from phase II trial for relapsed acute myeloid leukemia

There is a significant need for new treatments for patients with relapsed acute myeloid leukemia, a rare cancer of the

01/04/2019

Researchers identify experimental immunotherapy approach to target acute myeloid leukemia

University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential way to target a subtype of acute

11/08/2018

Quantitative 3D analysis of bone tools sheds light on ancient manufacture and use: Novel technique provides controlled experimental protocol for archeological investigations

Quantitative three-dimensional analysis of bone wear patterns can provide insight into the manufacture and use of early human tools, according

10/15/2018

Delving where few others have gone, leukemia researchers open new path

A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one

09/13/2018

Researchers solve a central mystery of a baffling high-risk leukemia

St. Jude Children’s Research Hospital investigators have unraveled the origins and identified mutations associated with a perplexing form of acute

08/24/2018

For first time in 40 years, cure for acute leukemia within reach

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has

08/10/2018

Melanoma linked with CLL, close monitoring recommended

While studying a large group of individuals with chronic lymphocytic leukemia (CLL), a Wilmot Cancer Institute scientific team made an

07/30/2018

Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia

Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the

07/24/2018

FDA approves tibsovo for acute myeloid leukemia

(HealthDay)—Tibsovo (ivosidenib) tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid

07/21/2018

Discovery of kidney cancer driver could lead to new treatment strategy

University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have